[HTML][HTML] NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low …
NCD Countdown - Lancet (London, England), 2022 - ncbi.nlm.nih.gov
Most countries have made little progress in achieving the Sustainable Development Goal
(SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable …
(SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable …
[HTML][HTML] Sialylated glycan bindings from SARS-CoV-2 spike protein to blood and endothelial cells govern the severe morbidities of COVID-19
DE Scheim, P Vottero, AD Santin, AG Hirsh - International journal of …, 2023 - mdpi.com
Consistent with well-established biochemical properties of coronaviruses, sialylated glycan
attachments between SARS-CoV-2 spike protein (SP) and host cells are key to the virus's …
attachments between SARS-CoV-2 spike protein (SP) and host cells are key to the virus's …
[HTML][HTML] Fractional order modelling of omicron SARS-CoV-2 variant containing heart attack effect using real data from the United Kingdom
In this study, a new approach to COVID-19 pandemic is presented. In this context, a
fractional order pandemic model is developed to examine the spread of COVID-19 with and …
fractional order pandemic model is developed to examine the spread of COVID-19 with and …
[HTML][HTML] NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low …
DA Watkins, WT Msemburi, SJ Pickersgill, Y Kawakatsu… - The Lancet, 2022 - thelancet.com
Most countries have made little progress in achieving the Sustainable Development Goal
(SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable …
(SDG) target 3.4, which calls for a reduction in premature mortality from non-communicable …
Biomarkers associated with severe COVID-19 among populations with high cardiometabolic risk: a 2-sample mendelian randomization study
Importance Cardiometabolic parameters are established risk factors for COVID-19 severity.
The identification of causal or protective biomarkers for COVID-19 severity may facilitate the …
The identification of causal or protective biomarkers for COVID-19 severity may facilitate the …
[HTML][HTML] COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment
L Ortega-Paz, AH Talasaz… - … in thrombosis and …, 2022 - thieme-connect.com
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
Risk of cardiovascular events after COVID-19
LG Tereshchenko, A Bishop, N Fisher-Campbell… - The American journal of …, 2022 - Elsevier
We aimed to determine absolute and relative risks of either symptomatic or asymptomatic
SARS-CoV-2 infection for late cardiovascular (CV) events and all-cause mortality. We …
SARS-CoV-2 infection for late cardiovascular (CV) events and all-cause mortality. We …
Nitric oxide-mediated cutaneous microvascular function is not altered in young adults following mild-to-moderate SARS CoV-2 infection
Vascular dysfunction has been reported in adults who have recovered from COVID-19. To
date, no studies have investigated the underlying mechanisms of persistent COVID-19 …
date, no studies have investigated the underlying mechanisms of persistent COVID-19 …
[HTML][HTML] Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes
COVID-19 vaccines have been instrumental tools in the fight against SARS-CoV-2 helping
to reduce disease severity and mortality. At the same time, just like any other therapeutic …
to reduce disease severity and mortality. At the same time, just like any other therapeutic …
[HTML][HTML] Casirivimab+ imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles
Severe, protracted symptoms are associated with poor outcomes in severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. In a placebo-controlled study of …
syndrome coronavirus 2 (SARS-CoV-2) infection. In a placebo-controlled study of …